Mid-sized Biotech looking for cost effective way to run their own study.

This is a mid-size company of about 300 employees that had been a Clintrial and Clintrace customer for 3 years. They faced the common situation of not having the resources and internal knowledge to adequately manage their system environment. As a result, they were outsourcing most of their studies but wanted to bring the data management back in-house.

PharmaPros was able to offer a solution by providing key services to develop their internal resources for managing clinical trials. In addition, PharmaPros was able to move their system environment to NCompass. Our team worked with them in the analysis and design of their now current business processes, development of standard study designs, standard workflow and internal SOPs.

PharmaPros enabled this client to build the knowledge and compliant processes to support the management of their clinical trials in-house, while allowing them to outsource the management of the technology through NCompass. A fully functional data management group was launched; PharmaPros continues to support their staff in providing study data management and clinical trials management as needed.

Subsidiary of large pharma needs to out source complete study management.

This client is a division of a large global pharmaceutical company who was left without a system and support for their medical imaging studies as a result of a recent merger/acquisition. The options for support from the parent company posed risks for lengthy delays, less than adequate experience with their unique study design needs, and corporate bureaucracy.

PharmaPros was awarded a contract to manage twelve new Phase II, III, and IV studies and over thirty five completed studies. Through our NCompass solution we were able to deliver a suite of services and technology including a compliant system and procedures, project management, and the full-range of study, data management and bio-statistical support to enable them meet their research timelines and deliverables.

As a result, this client has awarded PharmaPros 7 additional studies, allowing them to focus of the development programs and regulatory timelines for the launch of new products in near future.